Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula

AgencyDepartment of Health and Human Services

Subagency / OfficeOffice of Assistant Secretary for Preparedness and Response / Barda - Aspr / Daappo / Barda Dcma

Notice TypeAward Notice

Solicitation NumberBAA-23-100-SOL-00004

NAICS Code

PostedSeptember 25, 2026

Response DeadlineNo deadline specified

Performance LocationJersey City, NJ

View original listing on SAM.gov →

Notice Description

Full notice description available on SAM.gov.

Contacts

Audrey Glover (Primary) · audrey.glover@hhs.gov
Veronica Stroud · veronica.stroud@hhs.gov

Capabilities Sought

Relevant technical capability and customer experience
Qualified personnel and scalable delivery capacity
Documented quality, security, and compliance practices
Competitive rates and responsive teaming support

Partner Response

Responses to this opportunity are submitted through SAM.gov — GovConUnited doesn't collect or forward them. Follow the notice's instructions on SAM.gov to express interest or respond.